Qyuns Therapeutics Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	4,707	4,236	1,639	-	-	-
Market Cap Growth	136.03%	158.47%	-	-	-	-
Enterprise Value	4,176	4,309	1,494	-	-	-
Last Close Price	20.96	18.78	7.38	-	-	-
PE Ratio	13.40	12.11	-	-	-	-
PS Ratio	5.24	4.72	9.70	-	-	-
PB Ratio	6.23	5.61	6.97	-	-	-
P/TBV Ratio	6.12	5.50	6.83	-	-	-
P/FCF Ratio	-	9.52	-	-	-	-
P/OCF Ratio	10.58	9.52	-	-	-	-
EV/Sales Ratio	4.65	4.80	8.84	-	-	-
EV/EBITDA Ratio	10.69	11.08	-	-	-	-
EV/EBIT Ratio	11.77	12.14	-	-	-	-
EV/FCF Ratio	-	9.68	-	-	-	-
Debt / Equity Ratio	0.85	0.85	2.39	1.15	0.45	0.41
Debt / EBITDA Ratio	1.65	1.65	-	-	-	-
Debt / FCF Ratio	1.45	1.45	-	-	-	-
Net Debt / Equity Ratio	-0.68	-0.68	-0.13	-0.10	-0.48	-0.47
Net Debt / EBITDA Ratio	-1.32	-1.32	0.09	0.06	1.08	2.12
Net Debt / FCF Ratio	-1.16	-1.16	0.16	0.10	1.30	1.83
Asset Turnover	0.63	0.63	0.18	-	0.01	-
Inventory Turnover	15.70	15.70	18.73	-	-	-
Quick Ratio	2.11	2.11	1.36	1.50	5.06	9.03
Current Ratio	2.22	2.22	1.43	1.66	5.21	9.30
Return on Equity (ROE)	68.31%	68.31%	-133.98%	-108.33%	-45.74%	-
Return on Assets (ROA)	15.43%	15.43%	-24.04%	-35.11%	-19.27%	-
Return on Capital Employed (ROCE)	29.10%	29.10%	-61.80%	-94.60%	-35.50%	-18.00%
Earnings Yield	7.43%	8.26%	-21.79%	-	-	-
FCF Yield	-	10.50%	-12.16%	-	-	-
Buyback Yield / Dilution	-1.94%	-1.94%	-6.70%	-15.67%	-52.95%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.